Corticosteroid insensitivity of chemokine expression in airway smooth muscle of patients with severe asthma.

[1]  K. Chung,et al.  p38 mitogen-activated protein kinase pathways in asthma and COPD. , 2011, Chest.

[2]  R. Hickey,et al.  Nuclear protein isoforms: Implications for cancer diagnosis and therapy , 2011, Journal of cellular biochemistry.

[3]  Martyn R Partridge,et al.  Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization Consultation on Severe Asthma. , 2010, The Journal of allergy and clinical immunology.

[4]  K. Chung,et al.  Corticosteroid insensitivity in severe asthma: significance, mechanisms and aetiology , 2010, Internal medicine journal.

[5]  Jing Liu,et al.  p38 mitogen-activated protein kinase up-regulates NF-kappaB transcriptional activation through RelA phosphorylation during stretch-induced myogenesis. , 2010, Biochemical and biophysical research communications.

[6]  K. Chung,et al.  Inflammatory biomarkers in airways of patients with severe asthma compared with non‐severe asthma , 2009, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[7]  C. Brightling,et al.  Human Airway Smooth Muscle Cells from Asthmatic Individuals Have CXCL8 Hypersecretion Due to Increased NF-κB p65, C/EBPβ, and RNA Polymerase II Binding to the CXCL8 Promoter1 , 2009, The Journal of Immunology.

[8]  R. Panettieri,et al.  Vitamin D and glucocorticoids differentially modulate chemokine expression in human airway smooth muscle cells , 2008, British journal of pharmacology.

[9]  I. Adcock,et al.  Relative corticosteroid insensitivity of alveolar macrophages in severe asthma compared with non-severe asthma , 2008, Thorax.

[10]  S. Wenzel,et al.  Cell-specific activation profile of extracellular signal-regulated kinase 1/2, Jun N-terminal kinase, and p38 mitogen-activated protein kinases in asthmatic airways. , 2008, The Journal of allergy and clinical immunology.

[11]  K. Chung,et al.  Fluticasone, but not salmeterol, reduces cigarette smoke-induced production of interleukin-8 in human airway smooth muscle. , 2008, Pulmonary pharmacology & therapeutics.

[12]  J. Vernejoux,et al.  Bronchial smooth muscle remodeling involves calcium-dependent enhanced mitochondrial biogenesis in asthma , 2007, The Journal of experimental medicine.

[13]  W. Busse,et al.  Severe asthma: lessons from the Severe Asthma Research Program. , 2007, The Journal of allergy and clinical immunology.

[14]  A. Greenough,et al.  Extracellular matrix regulates enhanced eotaxin expression in asthmatic airway smooth muscle cells. , 2006, American journal of respiratory and critical care medicine.

[15]  I. Adcock,et al.  Relative corticosteroid insensitivity of peripheral blood mononuclear cells in severe asthma. , 2006, American journal of respiratory and critical care medicine.

[16]  J. Vernejoux,et al.  Fraktalkine Produced by Airway Smooth Muscle Cells Contributes to Mast Cell Recruitment in Asthma1 , 2006, The Journal of Immunology.

[17]  C. Lemière,et al.  Differences in airway remodeling between subjects with severe and moderate asthma. , 2005, The Journal of allergy and clinical immunology.

[18]  D. Robinson,et al.  Severe asthma treatment: need for characterising patients , 2005, The Lancet.

[19]  K. Chung,et al.  Fractalkine/CX3CL1 production by human airway smooth muscle cells: induction by IFN-γ and TNF-α and regulation by TGF-β and corticosteroids , 2004 .

[20]  L. Ou,et al.  Superantigen-induced corticosteroid resistance of human T cells occurs through activation of the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase (MEK-ERK) pathway. , 2004, The Journal of allergy and clinical immunology.

[21]  Z. Szatmáry,et al.  Inhibition of Glucocorticoid Receptor-mediated Transcriptional Activation by p38 Mitogen-activated Protein (MAP) Kinase* , 2004, Journal of Biological Chemistry.

[22]  J. Dean,et al.  The involvement of AU-rich element-binding proteins in p38 mitogen-activated protein kinase pathway-mediated mRNA stabilisation. , 2004, Cellular signalling.

[23]  M. Bihl,et al.  Dysfunctional interaction of C/EBPalpha and the glucocorticoid receptor in asthmatic bronchial smooth-muscle cells. , 2004, The New England journal of medicine.

[24]  P. Rothman,et al.  Enhancement of MEK/ERK signaling promotes glucocorticoid resistance in CD4+ T cells , 2004 .

[25]  K. Chung,et al.  Fractalkine/CX3CL1 production by human airway smooth muscle cells: induction by IFN-gamma and TNF-alpha and regulation by TGF-beta and corticosteroids. , 2004, American journal of physiology. Lung cellular and molecular physiology.

[26]  P. Rothman,et al.  Enhancement of MEK/ERK signaling promotes glucocorticoid resistance in CD4+ T cells. , 2004, The Journal of clinical investigation.

[27]  S. Durham,et al.  The CX3C chemokine fractalkine in allergic asthma and rhinitis. , 2003, The Journal of allergy and clinical immunology.

[28]  M. Aubier,et al.  Airway structural alterations selectively associated with severe asthma. , 2003, American journal of respiratory and critical care medicine.

[29]  H. Nakano,et al.  Phosphorylation of serine 276 is essential for p65 NF-kappaB subunit-dependent cellular responses. , 2003, Biochemical and biophysical research communications.

[30]  P. Debré,et al.  Cloning and functional characterization of the human fractalkine receptor promoter regions. , 2002, The Biochemical journal.

[31]  I. Adcock,et al.  p38 Mitogen-activated protein kinase-induced glucocorticoid receptor phosphorylation reduces its activity: role in steroid-insensitive asthma. , 2002, The Journal of allergy and clinical immunology.

[32]  P. Jeffery.  Remodeling in asthma and chronic obstructive lung disease. , 2001, American journal of respiratory and critical care medicine.

[33]  K. Chung,et al.  Severe asthma: definition and mechanisms , 2001, Allergy.

[34]  M. Tamm,et al.  Airway smooth muscle cell proliferation is increased in asthma. , 2001, American journal of respiratory and critical care medicine.

[35]  M. Cobb,et al.  Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. , 2001, Endocrine reviews.

[36]  J Bousquet,et al.  Asthma. From bronchoconstriction to airways inflammation and remodeling. , 2000, American journal of respiratory and critical care medicine.

[37]  S. Spector,et al.  Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. American Thoracic Society. , 2000, American journal of respiratory and critical care medicine.

[38]  C. Manthey,et al.  Cytokine mRNA decay is accelerated by an inhibitor of p38-mitogen-activated protein kinase , 1999, Inflammation Research.

[39]  A. Sousa,et al.  In vivo resistance to corticosteroids in bronchial asthma is associated with enhanced phosyphorylation of JUN N-terminal kinase and failure of prednisolone to inhibit JUN N-terminal kinase phosphorylation. , 1999, The Journal of allergy and clinical immunology.

[40]  J. Mitchell,et al.  Induction of eotaxin expression and release from human airway smooth muscle cells by IL‐1β and TNFα: effects of IL‐10 and corticosteroids , 1999 .

[41]  K. Chung,et al.  Induction of eotaxin expression and release from human airway smooth muscle cells by IL-1beta and TNFalpha: effects of IL-10 and corticosteroids. , 1999, British journal of pharmacology.

[42]  K. Chung,et al.  Expression and release of interleukin-8 by human airway smooth muscle cells: inhibition by Th-2 cytokines and corticosteroids. , 1998, American journal of respiratory cell and molecular biology.

[43]  S. Johnson,et al.  Synthetic functions of airway smooth muscle in asthma. , 1997, Trends in pharmacological sciences.

[44]  K. Chung,et al.  Human airway smooth muscle cells express and release RANTES in response to T helper 1 cytokines: regulation by T helper 2 cytokines and corticosteroids. , 1997, Journal of immunology.